- Home
- RVMDW vs REGCP Comparison
RVMDW vs REGCP Comparison
Compare RVMDW & REGCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVMDW
- REGCP
- Stock Information
- Founded
- RVMDW N/A
- REGCP N/A
- Country
- RVMDW United States
- REGCP United States
- Employees
- RVMDW 490
- REGCP 497
- Industry
- RVMDW
- REGCP
- Sector
- RVMDW
- REGCP
- Exchange
- RVMDW Nasdaq
- REGCP Nasdaq
- Market Cap
- RVMDW N/A
- REGCP N/A
- IPO Year
- RVMDW N/A
- REGCP N/A
- Fundamental
- Price
- RVMDW $0.18
- REGCP $23.61
- Analyst Decision
- RVMDW
- REGCP
- Analyst Count
- RVMDW 0
- REGCP 0
- Target Price
- RVMDW N/A
- REGCP N/A
- AVG Volume (30 Days)
- RVMDW N/A
- REGCP N/A
- Earning Date
- RVMDW N/A
- REGCP N/A
- Dividend Yield
- RVMDW N/A
- REGCP N/A
- EPS Growth
- RVMDW N/A
- REGCP N/A
- EPS
- RVMDW N/A
- REGCP N/A
- Revenue
- RVMDW N/A
- REGCP N/A
- Revenue This Year
- RVMDW N/A
- REGCP N/A
- Revenue Next Year
- RVMDW N/A
- REGCP N/A
- P/E Ratio
- RVMDW N/A
- REGCP N/A
- Revenue Growth
- RVMDW N/A
- REGCP N/A
- 52 Week Low
- RVMDW N/A
- REGCP N/A
- 52 Week High
- RVMDW N/A
- REGCP N/A
- Technical
- Relative Strength Index (RSI)
- RVMDW N/A
- REGCP 36.71
- Support Level
- RVMDW N/A
- REGCP $23.34
- Resistance Level
- RVMDW N/A
- REGCP $23.60
- Average True Range (ATR)
- RVMDW 0.00
- REGCP 0.25
- MACD
- RVMDW 0.00
- REGCP -0.05
- Stochastic Oscillator
- RVMDW 0.00
- REGCP 28.18
About RVMDW Revolution Medicines Inc. Warrant
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
About REGCP Regency Centers Corporation
Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 483 properties, which includes over 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.